Corrigendum: Rethinking immunization programs through the life course approach.

[This corrects the article DOI: 10.3389/fpubh.2024.

Rethinking immunization programs through the life course approach.

The world continues to undergo a profound demographic shift toward increasing longevity -but quality of life is not improving correspondingly. At the same time, countries are taking stock of the negative impacts of the COVID-19 pandemic on national immunization programs. The pandemic exacerbated the declines in vaccination coverage for multiple vaccine-preventable diseases (VPD).

Health Science Research at a Regional Level: Insights From South America Comment on "The Roles of Regional Organisations in Strengthening Health Research Systems in Africa: Activities, Gaps, and Future Perspectives".

The article seeks to shed light on the role of regional organizations in strengthening health research systems in Africa, how they operate and how they work, as well as debts and future challenges. As can be observed also in South America, the continued strengthening of health research requires strategic thinking about the roles, comparative advantages, and capacity of regional organizations to facilitate the flourishing of health research systems. Health research is a strategic field for the transformation of socio-health inequalities on the one hand and the reduction of regional asymmetries on the other.

[Access to medicines and South-South cooperation: a case study on joint drug price negotiations in South America].

This article aims to analyze joint negotiation of prices on high-cost drugs, which began in 2015 in the frameworks of the Southern Common Market (Mercosur) and the Union of South American Nations (USAN), with the participation of the Pan-Americana Health Organization (PAHO). This is a case study based on document research and in-depth interviews, describing the first face-to-face stage in the price negotiations led by the Mercosur Ad Hoc Committee on Drug Price Negotiations. The process resulted in the establishment of price caps in South America for darunavir and sofosbuvir.